Novavax Inc. sell Bank of America Co.
Start price
20.08.25
/
50%
€7.64
Target price
20.08.26
€6.02
Performance (%)
-18.22%
Price
09.01.26
€6.25
Summary
This prediction is currently active. The prediction for Novavax Inc. shows a convincing performance of -18.22%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | 9.198% | 9.198% |
| iShares Core DAX® | 2.659% | 4.844% |
| iShares Nasdaq 100 | 0.916% | -0.554% |
| iShares Nikkei 225® | 2.426% | 1.598% |
| iShares S&P 500 | 1.230% | 1.039% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its "underperform" rating reaffirmed by analysts at Bank of America Corporation. They now have a $7.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat